Argentine Registry of Crohn's Disease and Ulcerative Colitis
Observational · No treatment assigned · 1 site · Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Epidemiology, Inflammatory Bowel Disease (IBD) and Therapy. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Age range not stated in the record
- Any sex
Some of the main requirements, copied from the record:
- Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic,…
There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 4250 participants are expected to take part.
- Start date: 2023-07-14.
- Main results expected around 2025-11-30 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Argentina.
Main thing being measured
- Demography (Observational from July-2023)
In the researchers’ words
RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Group (GADECCU).
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Epidemiology; Inflammatory Bowel Disease (IBD); Therapy |
| Lead sponsor | Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa |
| Enrollment | 4250 (estimated) |
| Start date | 2023-07-14 |
| Primary completion (est.) | 2025-11-30 |
| First posted | 2025-09-04 |
| Last updated | 2025-09-23 |
| Official title | Argentine Registry of Crohn's Disease and Ulcerative Colitis |
| ClinicalTrials.gov ID | NCT07155148 |
Interventions
- observational study (Other)
Observational registry without clinical interventions
Full eligibility criteria (from the record)
Inclusion Criteria: * Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic, laboratory, and histopathological aspects, as well as small bowel imaging studies Exclusion Criteria: * Suspected IBD diagnosis without confirmation * IBD patients with incomplete information about therapy and follow-up
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Privado Universitario de Cordoba | Córdoba, Córdoba Province | Argentina | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.